• 1
    US Renal Data System. USRDS 2001 Annual Report. Bethesda, MD: National Institute of Health, 2001 (
  • 2
    Parfrey PS, Vavasour HM, Gault MH. A prospective study of health status in dialysis and transplant patients. Transplant Proc 1988; 20: 12311232.
  • 3
    Muirhead N. Erythropoietin and renal transplantation. Kidney Int Suppl 1999; 69: S86S92.
  • 4
    Silberberg JS, Rahal DP, Patton R, Sniderman AD. Role of anemia in the pathogenesis of left ventricular hypertrophy in end-stage renal disease. Am J Cardiol 1989; 64: 222224.
  • 5
    Mann JFE. What are the short-term and long-term consequences of anemia in CRF patients? Nephrol Dial Transplant 1999; 14 (Suppl. 2): S29S36.
  • 6
    Kasiske BL, Guijarro C, Massy ZA, Wiederkehr MR, Ma JZ. Cardiovascular disease after renal transplantation. J Am Soc Nephrol 1996; 7: 158165.
  • 7
    Kasiske BL, Vazquez MA, Harmon WE et al. Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation. J Am Soc Nephrol 2000; 11 (Suppl. 15): S1S86.
  • 8
    Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 3141.
  • 9
    Vanwalleghem JF, Vanrenterghem YFC. Hematologic considerations of organ transplantation. In: GinnsLC, CosimiAB Morris, PJ, eds. Transplantation. Malden: Blackwell Science, 1999: 685695.
  • 10
    Ternero F, Prats D, Alvarez-Sala JL, Coronel F, Sanchez A, Barrientos A. Iron deficiency anemia after successful renal transplantation. J Urol 1993; 149: 13981400.
  • 11
    Moore LW, Smith SO, Winsett RP, Acchiardo SR, Gaber AO. Factors affecting erythropoietin production and correction of anemia in kidney transplant recipients. Clin Transplant 1994; 8: 358364.
  • 12
    Miles AM, Markell MS, Daskalakis P et al. Anemia following renal transplantation: erythropoietin response and iron deficiency. Clin Transplant 1997; 11: 313315.
  • 13
    Yorgin PD, Scandling JD, Belson A, Sanchez J, Alexander SR, Andreoni KA. Late post-transplant anemia in adult renal transplant recipients. An under-recognized problem? Am J Transplant 2002; 2: 429435.
  • 14
    Sun CH, Ward HJ, Paul WL, Koyle MA, Yanagawa N, Lee DBN. Serum erythropoietin levels after renal transplantation. N Engl J Med 1989; 321: 151157.
  • 15
    Besarab A, Caro J, Jarrell BE, Francos G, Erslev AJ. Dynamics of erythropoiesis following renal transplantation. Kidney Int 1987; 32: 526536.
  • 16
    Franklin TJ, Cook JM. The inhibition of nucleic acid synthesis by mycophenolic acid. Biochemistry 1969; 113: 515524.
  • 17
    European Mycophenolate Mofetil Cooperative Study Group. Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. Lancet 1995; 345: 13211325.
  • 18
    Sollinger HW. Mycophenolate Mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group. Transplantation 1995; 60: 225232.
  • 19
    Old CW, Flannery EP, Grogan TM. Azathioprine-induced pure red cell aplasia. JAMA 1978; 240: 552554.
  • 20
    Lezaic V, Djukanovic LJ, Pavlovic-Kentera V. Recombinant human erthropoietin treatment of anemia in renal transplant patients. Ren Fail 1995; 5: 12161222.
  • 21
    Traindl O, Barnas U, Franz M. Recombinant erythropoietin in renal transplant recipients with renal anemia. Clin Transplant 1994; 8: 4548.
  • 22
    Jindal KK, Hirsch DJ, Belitsky P, Whalen MA. Low-dose subcutaneous erythropoietin corrects anemia of renal transplant failure. Nephrol Dial Transplant 1992; 7: 142146.
  • 23
    Almond MK, Tailor D, Marsh FP, Raftery MJ, Cunningham J. Increased erythropoeitin requirements in patients with failed renal transplants returning to a dialysis programme. Nephrol Dial Transplant 1994; 9: 270273.